Pricing Log in Create free account

NRx Pharmaceuticals, Inc. (NRXP) vs Outlook Therapeutics, Inc. (OTLK)

NRx Pharmaceuticals, Inc. and Outlook Therapeutics, Inc. are both Biotechnology companies. NRx Pharmaceuticals, Inc. and Outlook Therapeutics, Inc. are of similar size ($121.7M and $117.3M). Outlook Therapeutics, Inc. has the higher net margin (5,253.4% vs −691.8%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Outlook Therapeutics, Inc. leads on 8 and NRx Pharmaceuticals, Inc. on 5.

Valuation

Metric NRXP OTLK Biotechnology median
P/E n/m n/m 8.50
P/S 28.84 n/m 9.71
P/B n/m n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 22.58 (73.15) 9.21
Earnings yield (21.15%) (213.12%) (33.15%)
Free cash flow yield (21.12%) (84.46%) (25.50%)

Profitability

Metric NRXP OTLK Biotechnology median
Gross margin 46.64% 195.62% 65.16%
Operating margin (586.15%) 4,781.76% 0.00%
Net margin (691.78%) 5,253.40% 0.00%
Free cash flow margin (609.02%) 4,826.38% 0.00%
Return on equity 131.22% 256.92% (56.36%)
Return on assets (120.41%) (251.66%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXP OTLK Biotechnology median
Revenue growth (TTM) — (113.55%) 6.02%
EPS growth (last fiscal year) 43.22% 55.81% 30.26%
Revenue growth, 5-year CAGR — (22.99%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXP OTLK Biotechnology median
Debt to equity (2.42) (1.75) 0.00
Current ratio 0.86 0.81 4.72
Net debt to EBITDA 0.48 (0.33) 0.96

Dividend

Metric NRXP OTLK Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric NRXP OTLK Biotechnology median
Market cap 117.34m 121.72m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack